.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

OncClub: Join the Chat on Trending Trials in Cancer
Final results from the Phase 3 ClarIDHy trial
Lively expert panel discussions featuring peer-to-peer exchanges
Long-term efficacy and safety of TRK fusion-positive lung cancer treatment

SpecialtySee All >

Biosimilars
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Head & Neck Cancers
Hematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Multiple Myeloma

Advertise
About OncLive
Editorial Board
CureToday.com
TargetedOnc.com
CancerNetwork.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

Treatment of Metastatic Colorectal Cancer

EP. 1: TRIBE Trial: First-Line Treatment of mCRC

September 29th 2013

EP. 2: PRIME Trial: RAS Mutations in Metastatic Colorectal Cancer

September 29th 2013

EP. 3: EPOC Studies: Preoperative Treatments in CRC

September 29th 2013

EP. 4: FIRE-3 Study: Cetuximab Versus Bevacizumab in mCRC

September 29th 2013

EP. 5: Predictive Value of RAS Mutations in mCRC

September 29th 2013

EP. 6: Case Study: Borderline Resectable mCRC

September 29th 2013

EP. 7: Maintenance Therapy in Metastatic Colorectal Cancer

September 29th 2013

EP. 8: Antiangiogenic Therapy in Metastatic Colorectal Cancer

September 29th 2013

EP. 9: Second-Line and Salvage Treatment of mCRC

September 29th 2013

EP. 10: Novel Therapies in Development for mCRC

September 29th 2013

EP. 11: Personalized Medicine in Colorectal Cancer

September 29th 2013